deferoxamine and cycloserine

deferoxamine has been researched along with cycloserine in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Abdelsayed, S; El Hage Chahine, JM; Ha Duong, NT; Hai, J; Hémadi, M; Serradji, N; Verbeke, P	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Basdeo, SA; Cahill, C; Cox, DJ; Gogan, KM; Gordon, SV; Keane, J; O'Connell, F; O'Sullivan, J; Phelan, JJ	1

Reviews

1 review(s) available for deferoxamine and cycloserine

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

2 other study(ies) available for deferoxamine and cycloserine

Article	Year
Design and synthesis of 3-isoxazolidone derivatives as new Chlamydia trachomatis inhibitors. Bioorganic & medicinal chemistry letters, 2014, Aug-15, Volume: 24, Issue:16 Topics: Animals; Anti-Bacterial Agents; Chlamydia trachomatis; Dose-Response Relationship, Drug; Drug Design; HeLa Cells; Humans; Isoxazoles; Mice; Microbial Sensitivity Tests; Molecular Structure; Oxazolidinones; Structure-Activity Relationship	2014
The Iron Chelator Desferrioxamine Increases the Efficacy of Bedaquiline in Primary Human Macrophages Infected with BCG. International journal of molecular sciences, 2021, Mar-13, Volume: 22, Issue:6 Topics: Amikacin; Antitubercular Agents; Bacterial Load; Cell Survival; Clofazimine; Cycloserine; Deferoxamine; Diarylquinolines; Drug Resistance, Bacterial; Drug Synergism; Gene Expression; Humans; Interferon-gamma; Interleukin-1beta; Interleukin-6; Iron; Iron Chelating Agents; Linezolid; Macrophages; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium bovis; Primary Cell Culture; Pyrazinamide	2021

Article

Year

Design and synthesis of 3-isoxazolidone derivatives as new Chlamydia trachomatis inhibitors.

Bioorganic & medicinal chemistry letters, 2014, Aug-15, Volume: 24, Issue:16

Topics: Animals; Anti-Bacterial Agents; Chlamydia trachomatis; Dose-Response Relationship, Drug; Drug Design; HeLa Cells; Humans; Isoxazoles; Mice; Microbial Sensitivity Tests; Molecular Structure; Oxazolidinones; Structure-Activity Relationship

2014

The Iron Chelator Desferrioxamine Increases the Efficacy of Bedaquiline in Primary Human Macrophages Infected with BCG.

International journal of molecular sciences, 2021, Mar-13, Volume: 22, Issue:6

Topics: Amikacin; Antitubercular Agents; Bacterial Load; Cell Survival; Clofazimine; Cycloserine; Deferoxamine; Diarylquinolines; Drug Resistance, Bacterial; Drug Synergism; Gene Expression; Humans; Interferon-gamma; Interleukin-1beta; Interleukin-6; Iron; Iron Chelating Agents; Linezolid; Macrophages; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium bovis; Primary Cell Culture; Pyrazinamide

2021